Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas
Mei Mei Chan, Amitesh C Roy, David I Watson, Tim Bright, Lorraine Sheehan-Hennessy, Graeme P Young, Damian Hussey, Susanne K Pedersen, Jean M Winter, Erin L Symonds · 2026
Read Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas by Mei Mei Chan, Amitesh C Roy, David I Watson, Tim Bright, Lorraine Sheehan-Hennessy, Graeme P Young, Damian Hussey, Susanne K Pedersen, Jean M Winter, Erin L Symonds (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13182566.txt.
Description
Mei Mei Chan and nine co-authors test a blood marker for predicting the course of stomach and food-pipe cancers, in a research paper from 2026. These cancers have poor survival, and planning treatment needs a clear view of risk. The marker is tumor DNA floating in the blood, flagged by a chemical change on two genes.
Among one hundred twenty-two patients, the test was positive in just over half. Positivity was more common in advanced disease and in spread to lymph nodes or beyond. Patients with a positive result relapsed sooner and died sooner, even after accounting for stage. The authors call for prospective trials of its use in monitoring.
Catalog record
| CREATOR | Mei Mei Chan, Amitesh C Roy, David I Watson, Tim Bright, Lorraine Sheehan-Hennessy, Graeme P Young, Damian Hussey, Susanne K Pedersen, Jean M Winter, Erin L Symonds |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |